Figure 1.
TMEM47 expression levels in relation to cisplatin-based TACE treatment in patients with HCC. (A) Expression levels of TMEM47 mRNA in tumor and non-tumor liver tissues of HCC patients not receiving TACE treatment. (B) Expression levels of TMEM47 mRNA in tumor tissues between HCC patients with complete response (response group) and without response (non-response group) after cisplatin TACE treatment. (C) Expression levels of TMEM47 mRNA in tumor tissues of HCC patients not receiving TACE treatment (non-TACE group) and non-response patients. TMEM47, transmembrane protein 47; TACE, transarterial chemoembolization; HCC, hepatocellular carcinoma.